首页> Vaccine> Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A

导出原文传递

翻译打印收藏纠错

第一作者： Epstein JE

作者： Epstein JE ^[1] ; Charoenvit Y ; Kester KE ; Wang RB ; Newcomer R ; Fitzpatrick

作者单位： Hoffman SL, Sanaria Inc, 1211 Parklawn Dr, Rockville, MD 20850, USA ^[1]

关键词 Dna vaccine Rts s Malaria Clinical trial Sequential immunization Falciparum circumsporozoite-protein Humoral immune-responses Plasmodium-falciparum Malaria vaccine Protective immunity Plasmid dna Immunogenicity Induction Efficacy Volunteers

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Vaccine

2004年22卷13/14期

1592-1603页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览4

点击下载本期目录封面

Vaccine

2004年22卷13/14期

1592-1603页

检索历史清除

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A

Vaccine

相似文献

同项目论文

Vaccine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A

Vaccine

相似文献

同项目论文

Vaccine

相关期刊

检索历史清除